Gene expression test measures risk of metastases in breast cancer patients

[News]

In Austria every year approx. 1,500 postmenopausal patients, that is, after the climacteric period, are affected by stage II breast cancer. This means that in these women tumour cells have already been found in the lymph nodes and that the risk of metastases appearing in the future course of the illness is significantly increased.

More... (http://www.news-medical.net/news/20130604/Gene-expression-test-measures-risk-of-metastases-in-breast-cancer-patients.aspx)